Moores Cancer Center
April 21, 2011
Welcome and OverviewDavid Brenner, M.D., Dean, UCSD School of MedicineApril 21, 2011Speakers: David Brenner Run Time: 03 minutes David Brenner, M.D., a distinguished physician-scientist, is Vice Chancellor for Health Sciences and Dean of the School of Medicine at the University... |
Primary Animal Models for Combination Therapy: The HALT ProgramDennis Carson, M.D., Moores Cancer CenterApril 21, 2011Speakers: Dennis Carson Run Time: 12 minutes Dennis Carson, M.D. is Director of the Rebecca and John Moores UCSD Cancer Center and Professor of Medicine at UCSD School of Medicine. He is also... |
Targeting the PI3K/mTOR Pathway in CancerChristian Rommel, Ph.D., IntellikineApril 21, 2011Speakers: Christian Rommel Run Time: 34 minutes Christian Rommel serves as Intellikine's Chief Scientific Officer. Dr. Rommel is responsible for the company's research, drug discovery and... |
PI3Kγ, a Convergent Molecular Target for the Suppression of Tumor Inflammation, Growth and ProgressionJudith Varner, Ph.D., Moores Cancer CenterApril 21, 2011Speakers: Judith Varner Run Time: 20 minutes The Varner Lab studies the molecular mechanisms by which the tumor microenvironment promotes tumor growth and metastasis. Our most recent focus is on... |
Keynote: Accelerating Drug Development and Biomarker Discovery: The I-SPY TrialsLaura Esserman, M.D., M.B.A., Carol Franc Buck Breast Care Center, UCSF Helen Diller Family Comprehensive Cancer CenterApril 21, 2011Speakers: Laura Esserman Run Time: 42 minutes Dr. Laura Esserman, MD, MBA, is a Professor of Surgery and Radiology at UCSF and is the Director of the Carol Franc Buck Breast Care Center, an... |
Unraveling Cancer Stem Cell Survival MechanismsCatriona Jamieson, M.D., Ph.D. and Kelly Frazer, Ph.D., Moores Cancer CenterApril 21, 2011Speakers: Catriona Jamieson, Kelly Frazer Run Time: 35 minutes Catriona Jamieson, M.D., Ph.D. is Assistant Professor of Medicine in the Division of Hematology-Oncology and Director for Stem Cell Research at... |
Control of Tumor Progression and Metastasis by Lymphocyte-Produced CytokinesMichael Karin, Ph.D., UCSD School of MedicineApril 21, 2011Speakers: Michael Karin Run Time: 30 minutes Dr. Karin made seminal contributions to the discipline of signal transduction describing how extracellular stimuli, including growth factors,... |
Targeting Raf by Allosteric Inhibition Offers New Therapeutic Opportunities in OncologyDavid Cheresh, Ph.D., Moores Cancer CenterApril 21, 2011Speakers: David Cheresh Run Time: 20 minutes David Cheresh studies the mechanism of action of signaling networks that regulate cancer growth and metastasis and focuses on new strategies for... |